Iovance Biotherapeutics Inc (IOVA) Q3 2024 Earnings Call Highlights: Surpassing Revenue ...

By Yahoo! Finance | Nov 8, 2024 at 08:13 AM EST

Frederick Vogt discusses IL-2 stocking levels with potential growth in 2025 due to steady numbers from major U.S. distributors. Improved manufacturing processes lead to increased comfort with preconditioning at ATCs. Month-over-month infusion growth is driven by manufacturing capacity and demand.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.